Cargando…
Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses
BACKGROUND: Adenoid cystic carcinomas are rare tumors with an indolent clinical course, but frequent local relapses. The identification of tumors with a higher relapse risk seems to be interesting. Hence we investigated parameters of glucose metabolism, which were found associated with poor prognosi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704178/ https://www.ncbi.nlm.nih.gov/pubmed/19545368 http://dx.doi.org/10.1186/1746-1596-4-18 |
_version_ | 1782168909453983744 |
---|---|
author | Völker, Hans-Ullrich Scheich, Matthias Berndt, Annette Haubitz, Imme Metzger, Alexandra Müller-Hermelink, Hans-Konrad Kämmerer, Ulrike Schmidt, Melanie |
author_facet | Völker, Hans-Ullrich Scheich, Matthias Berndt, Annette Haubitz, Imme Metzger, Alexandra Müller-Hermelink, Hans-Konrad Kämmerer, Ulrike Schmidt, Melanie |
author_sort | Völker, Hans-Ullrich |
collection | PubMed |
description | BACKGROUND: Adenoid cystic carcinomas are rare tumors with an indolent clinical course, but frequent local relapses. The identification of tumors with a higher relapse risk seems to be interesting. Hence we investigated parameters of glucose metabolism, which were found associated with poor prognosis in other malignancies. METHODS: Specimen of 29 patients were investigated immunohistochemically with antibodies against p-AKT, TKTL-1 (transketolase-like 1), M2PK (M2 pyruvate kinase), and GLUT-1. Proliferation was investigated by staining with Ki67. The tumors were located at the major or minor salivary glands. Only the typical cribriform subtype was investigated. The initial tumor stage was pT1 or pT2. RESULTS: Expression of p-AKT was significantly (P = 0.036) associated with a higher relapse risk in multivariate analysis. Low expression of M2PK was non-significantly (P = 0.065) predictive for a higher risk. TKTL-1 and GLUT-1 were expressed in the majority of cases, albeit not associated with relapse risk. CONCLUSION: Adenoid cystic carcinomas positive for p-AKT show a higher relapse risk. However, other parameters of glucose metabolism investigated here or proliferation (Ki67) were not predictive in this entity. Our findings demonstrate a possible background for therapeutic approaches targeting the inhibition of PI3K/AKT pathway. |
format | Text |
id | pubmed-2704178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27041782009-07-01 Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses Völker, Hans-Ullrich Scheich, Matthias Berndt, Annette Haubitz, Imme Metzger, Alexandra Müller-Hermelink, Hans-Konrad Kämmerer, Ulrike Schmidt, Melanie Diagn Pathol Research BACKGROUND: Adenoid cystic carcinomas are rare tumors with an indolent clinical course, but frequent local relapses. The identification of tumors with a higher relapse risk seems to be interesting. Hence we investigated parameters of glucose metabolism, which were found associated with poor prognosis in other malignancies. METHODS: Specimen of 29 patients were investigated immunohistochemically with antibodies against p-AKT, TKTL-1 (transketolase-like 1), M2PK (M2 pyruvate kinase), and GLUT-1. Proliferation was investigated by staining with Ki67. The tumors were located at the major or minor salivary glands. Only the typical cribriform subtype was investigated. The initial tumor stage was pT1 or pT2. RESULTS: Expression of p-AKT was significantly (P = 0.036) associated with a higher relapse risk in multivariate analysis. Low expression of M2PK was non-significantly (P = 0.065) predictive for a higher risk. TKTL-1 and GLUT-1 were expressed in the majority of cases, albeit not associated with relapse risk. CONCLUSION: Adenoid cystic carcinomas positive for p-AKT show a higher relapse risk. However, other parameters of glucose metabolism investigated here or proliferation (Ki67) were not predictive in this entity. Our findings demonstrate a possible background for therapeutic approaches targeting the inhibition of PI3K/AKT pathway. BioMed Central 2009-06-19 /pmc/articles/PMC2704178/ /pubmed/19545368 http://dx.doi.org/10.1186/1746-1596-4-18 Text en Copyright © 2009 Völker et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Völker, Hans-Ullrich Scheich, Matthias Berndt, Annette Haubitz, Imme Metzger, Alexandra Müller-Hermelink, Hans-Konrad Kämmerer, Ulrike Schmidt, Melanie Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title | Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title_full | Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title_fullStr | Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title_full_unstemmed | Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title_short | Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
title_sort | expression of p-akt characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704178/ https://www.ncbi.nlm.nih.gov/pubmed/19545368 http://dx.doi.org/10.1186/1746-1596-4-18 |
work_keys_str_mv | AT volkerhansullrich expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT scheichmatthias expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT berndtannette expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT haubitzimme expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT metzgeralexandra expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT mullerhermelinkhanskonrad expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT kammererulrike expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses AT schmidtmelanie expressionofpaktcharacterizesadenoidcysticcarcinomasofheadandneckwithahigherriskfortumorrelapses |